These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 29577894)

  • 1. Bilateral quinolinic acid-induced lipid peroxidation, decreased striatal monoamine levels and neurobehavioral deficits are ameliorated by GIP receptor agonist D-Ala
    Verma MK; Goel R; Nandakumar K; Nemmani KVS
    Eur J Pharmacol; 2018 Jun; 828():31-41. PubMed ID: 29577894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of D-Ala
    Verma MK; Goel R; Nandakumar K; Nemmani KVS
    Eur J Pharmacol; 2017 Jun; 804():38-45. PubMed ID: 28366809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertraline and venlafaxine improves motor performance and neurobehavioral deficit in quinolinic acid induced Huntington's like symptoms in rats: Possible neurotransmitters modulation.
    Gill JS; Jamwal S; Kumar P; Deshmukh R
    Pharmacol Rep; 2017 Apr; 69(2):306-313. PubMed ID: 28178592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Effect of Spermidine Against Excitotoxic Neuronal Death Induced by Quinolinic Acid in Rats: Possible Neurotransmitters and Neuroinflammatory Mechanism.
    Jamwal S; Singh S; Kaur N; Kumar P
    Neurotox Res; 2015 Aug; 28(2):171-84. PubMed ID: 26078029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
    Colle D; Hartwig JM; Soares FA; Farina M
    Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
    Ryu JK; Kim SU; McLarnon JG
    Exp Neurol; 2004 May; 187(1):150-9. PubMed ID: 15081596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington's disease like symptoms in rats: behavioral, biochemical, cellular and histological evidences.
    Kumar A; Chaudhary T; Mishra J
    Eur J Pharmacol; 2013 Nov; 720(1-3):16-28. PubMed ID: 24211676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats.
    Kalonia H; Kumar P; Kumar A; Nehru B
    Neuroscience; 2010 Nov; 171(1):284-99. PubMed ID: 20813166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats.
    Kalonia H; Kumar A
    Life Sci; 2011 Apr; 88(17-18):784-91. PubMed ID: 21362433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between behavioural and oxidative parameters in a rat quinolinic acid model of Huntington's disease: protective effect of melatonin.
    Antunes Wilhelm E; Ricardo Jesse C; Folharini Bortolatto C; Wayne Nogueira C
    Eur J Pharmacol; 2013 Feb; 701(1-3):65-72. PubMed ID: 23340221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
    Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
    Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats.
    Kalonia H; Kumar P; Nehru B; Kumar A
    Indian J Exp Biol; 2009 Nov; 47(11):880-92. PubMed ID: 20099461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
    Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A
    Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective Activity of Curcumin in Combination with Piperine against Quinolinic Acid Induced Neurodegeneration in Rats.
    Singh S; Kumar P
    Pharmacology; 2016; 97(3-4):151-60. PubMed ID: 26828892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.
    Popoli P; Pintor A; Domenici MR; Frank C; Tebano MT; Pèzzola A; Scarchilli L; Quarta D; Reggio R; Malchiodi-Albedi F; Falchi M; Massotti M
    J Neurosci; 2002 Mar; 22(5):1967-75. PubMed ID: 11880527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.
    Araujo DM; Hilt DC
    Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of mitochondrial NAD(+)/FAD(+)-linked state-3 respiration by caffeine attenuates quinolinic acid induced motor impairment in rats: implications in Huntington's disease.
    Mishra J; Kumar A
    Pharmacol Rep; 2014 Dec; 66(6):1148-55. PubMed ID: 25443748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of naringin, a flavone glycoside in quinolinic acid-induced neurotoxicity: Possible role of PPAR-γ, Bax/Bcl-2, and caspase-3.
    Cui J; Wang G; Kandhare AD; Mukherjee-Kandhare AA; Bodhankar SL
    Food Chem Toxicol; 2018 Nov; 121():95-108. PubMed ID: 30130594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington's disease through inhibition of NF-κB mediated neuroinflammatory markers and activation of cAMP/CREB/BDNF signaling pathway.
    Saroj P; Bansal Y; Singh R; Akhtar A; Sodhi RK; Bishnoi M; Sah SP; Kuhad A
    Inflammopharmacology; 2021 Apr; 29(2):499-511. PubMed ID: 33517508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Licofelone attenuates quinolinic acid induced Huntington like symptoms: possible behavioral, biochemical and cellular alterations.
    Kalonia H; Kumar P; Kumar A
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):607-15. PubMed ID: 21237233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.